808 related articles for article (PubMed ID: 27574990)
21. Simple nanoliposomes encapsulating
Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
[TBL] [Abstract][Full Text] [Related]
22. Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method.
Nordly P; Rose F; Christensen D; Nielsen HM; Andersen P; Agger EM; Foged C
J Control Release; 2011 Mar; 150(3):307-17. PubMed ID: 21111765
[TBL] [Abstract][Full Text] [Related]
23. Routing dependent immune responses after experimental R848-adjuvated vaccination.
van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
[TBL] [Abstract][Full Text] [Related]
24. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
[TBL] [Abstract][Full Text] [Related]
25. Co-immunization with L-Myc enhances CD8
Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
[TBL] [Abstract][Full Text] [Related]
26. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
[TBL] [Abstract][Full Text] [Related]
27. A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes.
Agallou M; Margaroni M; Tsanaktsidou E; Badounas F; Kammona O; Kiparissides C; Karagouni E
J Control Release; 2023 Apr; 356():386-401. PubMed ID: 36893900
[TBL] [Abstract][Full Text] [Related]
28. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
Neuenhahn M; Busch DH
Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
[TBL] [Abstract][Full Text] [Related]
29. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
[TBL] [Abstract][Full Text] [Related]
30. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
31. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
[TBL] [Abstract][Full Text] [Related]
32. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
33. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
[TBL] [Abstract][Full Text] [Related]
34. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
[TBL] [Abstract][Full Text] [Related]
35. Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C).
Wick DA; Martin SD; Nelson BH; Webb JR
Vaccine; 2011 Jan; 29(5):984-93. PubMed ID: 21115055
[TBL] [Abstract][Full Text] [Related]
36. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
[TBL] [Abstract][Full Text] [Related]
37. PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8
Sekiya T; Yamagishi J; Gray JHV; Whitney PG; Martinelli A; Zeng W; Wong CY; Sugimoto C; Jackson DC; Chua BY
Biomaterials; 2017 Aug; 137():61-72. PubMed ID: 28544973
[TBL] [Abstract][Full Text] [Related]
38. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
[TBL] [Abstract][Full Text] [Related]
39. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
Kamath AT; Mastelic B; Christensen D; Rochat AF; Agger EM; Pinschewer DD; Andersen P; Lambert PH; Siegrist CA
J Immunol; 2012 May; 188(10):4828-37. PubMed ID: 22504654
[TBL] [Abstract][Full Text] [Related]
40. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
